Gastrin-releasing peptide receptors regulate proliferation of C6 glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism

Current Neurovascular Research

Volumn 5, Issue 2, 2008, Pages 99-105

  Flores, Debora Gazzana ^a   De Farias, Caroline Brunetto ^a   Leites, Juliano ^a   De Oliveira, Marianne Schrader ^a   Lima, Rodrigo Cruz ^a   Tamajusuku, Alessandra Sayuri Kikuchi ^a   Di Leone, Luciane Pons ^a   Meurer, Luise ^a   Brunetto, Algemir Lunardi ^a   Schwartsmann, Gilberto ^a   Lenz, Guido ^a   Roesler, Rafael ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bombesin like peptides; Brain tumor; Gastrin releasing peptide receptor; Glioma; Phosphoinositide 3 kinase; RC 3095

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BOMBESIN; GASTRIN RELEASING PEPTIDE RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RC 3095;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTINEOPLASTIC AGENTS; BOMBESIN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; ENZYME INHIBITORS; GLIOMA; MORPHOLINES; PEPTIDE FRAGMENTS; RATS; RECEPTORS, BOMBESIN;

EID: 45249112170     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720208784310240     Document Type: Article

References (45)

1. Bajo, AM, Schally, AV, Groot, K, Szepeshazi, K. (2004) Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers. Br J Cancer 90: 245-252.
2. Bajo, AM, Schally, AV, Krupa, M, Hebert, F, Groot, K, Szepeshazi, K. (2002) Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes. Proc Natl Acad Sci U S A 99: 3836-3841.
3. Barth, RF. (1998) Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36: 91-102.
4. Benda, P, Lightbody, J, Sato, G, Levine, L, Sweet, W. (1968) Differentiated rat glial cell strain in tissue culture. Science 161: 370-371.
5. Carpentier, AF. (2005) Neuro-oncology: the growing role of chemotherapy in glioma. Lancet Neurol 4: 4-5.
6. Casanueva, FF, Perez, FR, Casabiell, X, Camina, JP, Cai, RZ, Schally, AV. (1996) Correlation between the effects of bombesin antagonists on cell proliferation and intracellular calcium concentration in Swiss 3T3 and HT-29 cell lines. Proc Natl Acad Sci U S A 93: 1406-1411.
7. Castellino, RC, Durden, DL. (2007) Mechanisms of disease: the PI3K-Akt-PTEN signaling node - an intercept point for the control of angiogenesis in brain tumors. Nat Clin Pract Neurol 3: 682-693.
8. Cornelio, D, Roesler, R, Schwartsmann, G. (2007) Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol 18: 1457-1466.
9. Dantas, AS, Luft, T, Henriques, JA, Schwartsmann, G, Roesler, R. (2006) Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system. Peptides 27: 2307-2312.
10. Gonzalez, N, Moody, TW, Igarashi, H, Ito, T, Jensen, RT. (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15: 58-64.
11. Grobben, B, De Deyn, PP, Slegers, H. (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310: 257-270.
12. Halmos, G, Schally, AV. (1997) Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Proc Natl Acad Sci U S A 94: 956-960.
13. Hellmich, MR, Ives, KL, Udupi, V, Soloff, MS, Greeley GH Jr, Christensen BN, Townsend, CM Jr. (1999) Multiple protein kinase pathways are involved in gastrin-releasing peptide receptor-regulated secretion. J Biol Chem 274: 23901-23909.
14. Ishola, TA, Kang, J, Qiao, J, Evers, BM, Chung, DH. (2007) Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells. Biochim Biophys Acta 1770: 927-932.
15. Jensen, RT, Battey, JF, Spindel, ER, Benya, RV. (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev (in press).
16. Kiaris, H, Schally, AV, Sun, B, Armatis, P, Groot, K. (1999) Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide. Oncogene 18: 7168-7173.
17. Kim, HJ, Evers, BM, Litvak, DA, Hellmich, MR, Townsend, CM Jr. (2000) Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA. Am J Physiol Cell Physiol 279: C326-C334.
18. Knobbe, CB, Merlo, A, Reifenberger, G. (2002) Pten signaling in gliomas. Neuro Oncol 4: 196-211.
19. Koppan, M, Halmos, G, Arencibia, JM, Lamharzi, N, Schally, AV. (1998) Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma. Cancer 83: 1335-1343.
20. Lind, CR, Gray, CW, Pearson, AG, Cameron, RE, O'Carroll, SJ, Narayan, PJ, Lim, J, Dragunow, M. (2006) The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells. Neuroscience 141: 1925-1933.
21. Liu, X, Carlisle, DL, Swick, MC, Gaither-Davis, A, Grandis, JR, Siegfried, JM. (2007) Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib. Exp Cell Res 313: 1361-1372.
22. Merlo, A. (2003) Genes and pathways driving glioblastomas in humans and murine disease models. Neurosurg Rev 26: 145-158.
23. Moody, TW, Mahmoud, S, Staley, J, Naldini, L, Cirillo, D, South, V, Felder, S, Kris, R. (1989) Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide. J Mol Neurosci 1: 235-242.
24. Mulholland, PJ, Thirlwell, C, Brock, CS, Newlands, ES. (2005) Emerging targeted treatments for malignant glioma. Expert Opin Emerg Drugs 10: 845-854.
25. Newton, HB. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis. Expert Rev Anticancer Ther 4: 105-128.
26. Norden, AD, Wen, PY. (2006) Glioma therapy in adults. Neurologist 12: 279-292.
27. Patel, O, Shulkes, A, Baldwin, GS. (2006) Gastrin-releasing peptide and cancer. Biochim Biophys Acta 1766: 23-41.
28. Pinski, J, Halmos, G, Schally, AV. (1993) Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett 71: 189-196.
29. Pinski, J, Schally, AV, Halmos, G, Szepeshazi, K, Groot K. (1994) Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res 54: 5895-5901.
30. Prados, MD, Levin V. (2000) Biology and treatment of malignant glioma. Semin Oncol 27(3 Suppl 6): 1-10.
31. Radulovic, S, Cai, RZ, Serfozo, P, Groot, K, Redding, TW, Pinski, J, Schally, AV. (1991) Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. Int J Pept Protein Res 38: 593-600.
32. Rich, JN, Bigner, DD. (2004) Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3: 430-446.
33. Roesler, R, Kopschina, MI, Rosa, RM, Henriques, JA, Souza, DO, Schwartsmann, G. (2004) RC-3095, a bombesin/gastrin-releasing peptide antagonist, impairs aversive but not recognition memory in rats. Eur J Pharmacol 486: 35-41.
34. Roesler, R, Meller, CA, Kopschina, MI, Souza, DO, Henriques, JA, Schwartsmann, G. (2003) Intrahippocampal infusion of the bombesin/gastrin- releasing peptide antagonist RC-3095 impairs inhibitory avoidance retention. Peptides 24: 1069-1074.
35. Sanson, M, Thillet, J, Hoang-Xuan, K. (2004) Molecular changes in gliomas. Curr Opin Oncol 16: 607-613.
36. Schwartsmann, G, DiLeone, LP, Horowitz, M, Schunemann, D, Cancella, A, Pereira, AS, Richter, M, Souza, F, da Rocha, AB, Souza, FH, Pohlmann, P, De Nucci, G. (2006) A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs 24: 403-412.
37. Schwartzbaum, JA, Fisher, JL, Aldape, KD, Wrensch, M. (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2: 494-503.
38. Sharif, M. (1998) Mitogenic signaling by substance P and bombesin-like neuropeptide receptors in astrocytic/glial brain tumor-derived cell lines. Int J Oncol 12: 273-286.
39. Sharif, TR, Luo, W, Sharif, M. (1997) Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway. Mol Cell Endocrinol 130: 119-130.
40. Staley, J, Coy, DH, Jensen, RT, Moody, TW. (1993) Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines. J Mol Neurosci 4: 29-40.
41. Stangelberger, A, Schally, AV, Varga, JL, Zarandi, M, Cai, RZ, Baker, B, Hammann, BD, Armatis, P, Kanashiro, CA. (2005) Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling. Eur J Cancer 41: 2735-2344.
42. Szepeshazi, K, Schally, AV, Halmos, G, Lamharzi, N, Groot, K, Horvath, JE. (1997) A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. Proc Natl Acad Sci U S A 94: 10913-10918.
43. Vivanco, I, Sawyers CL. (2002) The phosphatidylinositol 3-kinase Akt pathway in human cancer. Nat Rev Cancer 2: 489-501.
44. Xiao, D, Qu, X, Weber, HC. (2003) Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells. Cell Signal 15: 945-953.
45. Zhou, J, Chen, J, Mokotoff, M, Ball, ED. (2004) Targeting gastrin-releasing peptide receptors for cancer treatment. Anticancer Drugs 15: 921-927.